Mounjaro pens: the KwikPen explained

Each KwikPen contains four doses at the same strength — one injection per week for four weeks, then a fresh pen for the next month.
Six strengths are available in the UK: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg; the prescriber decides which dose is right based on clinical review, not patient preference.
The pen must be stored in the fridge at 2–8°C; for exact guidance on the limited room-temperature window, always check the Patient Information Leaflet that comes with the pen.
Used pens and needles are sharps and must be disposed of safely, never in household bins.

Each Mounjaro pen is a pre-filled, once-weekly subcutaneous injection containing tirzepatide — a dual GIP and GLP-1 receptor agonist licensed in the UK for weight management and type 2 diabetes. One pen delivers four weekly doses, and treatment always starts at 2.5mg before a prescriber titrates upward. As a prescription-only medicine, Mounjaro pens are only legally available following a clinical assessment. The NHS tirzepatide patient information page covers the basics clearly; the sections below go deeper on what the pen itself is, how to use it correctly, and what to do with it once it's empty.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Using Mounjaro pens correctly: technique, rotation and disposal

What NICE and clinical trials tell us about these pens in practice

The evidence base for tirzepatide is grounded in the SURMOUNT programme, and NICE's appraisal of tirzepatide (TA1026) assessed that evidence before recommending it for NHS use in eligible adults. SURMOUNT-1, which randomised 2,539 adults, found that participants at the 15mg dose achieved an average body-weight reduction of around 20–21% over 72 weeks. Those figures were generated by people using the KwikPen weekly, consistently and correctly, which is worth stating plainly, because the pen's design is part of why adherence in the trial held up as well as it did.

The pen is pre-filled and pre-set to the prescribed dose; there is no dial to turn, no cartridge to load. You attach a needle, select an injection site, press the button and the mechanism delivers the dose. That simplicity matters clinically: fewer steps means fewer opportunities for error. Still, correct technique (right site, right angle, rotating where you inject) does make a difference to both comfort and absorption.

A common belief is that the pen has to be used from the fridge immediately, straight from cold storage. In fact there is a limited window during which it may be held at room temperature, which is why the Patient Information Leaflet is the right place to check that detail rather than any general article. The leaflet is specific to your pen's batch and strength; a blog post isn't.

Injection sites, needle attachment and technique for Mounjaro pens

The three licensed injection sites for Mounjaro are the abdomen (avoiding a two-inch radius around the navel), the front or outer thigh, and the upper arm. Rotating between these sites (and rotating within each site) reduces the risk of local reactions and lipohypertrophy, a build-up of fatty tissue that can blunt absorption over time.

The pen itself does not come with a needle attached. You'll need to fit a compatible needle before each injection. Compatible needles for Mounjaro pens are stocked separately; a fresh needle should be used for every injection and removed immediately afterwards before capping the pen. Reusing needles blunts the tip and increases the risk of infection and injection-site pain, something our prescribers flag regularly because it seems like a small saving that isn't.

Before injecting, clean the chosen site with an alcohol swab and let the skin dry fully. Insert at a 90-degree angle (or 45 degrees if you have very little subcutaneous fat at the site), press the injection button firmly, and hold for a count of ten to ensure the full dose is delivered. You'll hear a click when the mechanism fires; keep the pen pressed against the skin until the ten seconds are up.

For a detailed walk-through of the injection process step by step, the Mounjaro injection guide covers technique in full.

What to do with Mounjaro pens once the four doses are used

An empty KwikPen is a clinical sharp. UK law and NHS guidance are clear: it cannot go into household recycling or a standard bin. Used pens and detached needles belong in an approved sharps container, which most councils collect free of charge via a sharps collection scheme, contact your local authority or ask your GP surgery for details.

A 1-litre sharps container is the right size for most people on a single monthly pen; it seals securely and meets the required standard for collection. Once a container is three-quarters full, seal it and arrange collection, don't overfill it.

If you are moving to a different strength or your prescription changes, return any unused sealed pens to a pharmacy for safe disposal rather than storing them indefinitely. Pens are matched to your prescribed dose; using a different strength without clinical authorisation is not appropriate. Questions about switching or pausing treatment belong with your prescriber, not the pen's label.

If you're weighing up the cost of ongoing treatment, a factual overview of how Mounjaro is priced across UK providers may help you understand what different services include.

Pens, supplies and getting a prescription through a regulated service

Mounjaro pens in the UK come only through a valid prescription issued following a clinical assessment. That assessment considers your BMI, any weight-related health conditions, current medicines and medical history. No legitimate service skips that step.

The Mounjaro injection pens page covers the different pen formats available by dose. If you're approaching the end of your current supply, the guidance on starting a new Mounjaro pen is worth reading before your next dose is due. And if you've seen references to packs supplying two or three pens at once, those are covered in the two-pen supply and three-pen supply pages respectively.

At nume, every prescription is reviewed by a GPhC-registered Independent Prescriber before any treatment is dispatched. If you'd like to find out whether tirzepatide is clinically suitable for you, check your eligibility with a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions